Policy Fellow Matt Rumsey wrote this post.
Here is Tuesday’s take on transparency-related news items, congressional committee hearings, transparency-related bills introduced in Congress, and transparency-related events.
- The Pharmaceutical Research and Manufactures of America, the drug lobby’s trade association, gave more than $9 million to politically active 501(c)(4) groups during the 2010 election season. (iWatch News)
- The major political committees focused on Governors follow state, not federal, campaign finance rules. They are registered as 527 groups and can actively solicit donations from corporate interests. (National Journal)
- Democratic lobbyists, who are barred from raising money for President Obama’s campaign, are not jumping to donate to Priorities USA, the super PAC supporting the president. (The Hill)
- The Senate may take up a version of the STOCK act passed by the house. Both chambers recently passed similar legislation, but no moves have been made to reconcile differences between the two versions. (Politico)
- A battle may be brewing over the issue of “open access” to government funded scientific research. But, neither opponents or proponents of the issue in Congress are itching for a fight and it appears more likely that a compromise will be negotiated. (New York Times)
- Opinion: Prosecuting whistleblowers is antithetical to open government. (Gov Fresh/Alex Howard)
Relevant committee hearings scheduled for 2/28:
- Government 2.0: GAO unveils new duplicative program report. Oversight and Government Reform. 9:30 am. 2154 RHOB. Full Committee Hearing.
Relevant bills introduced: